Opendata, web and dolomites

NAOS SIGNED

a disruptive implantable neurostimulator for the treatment of epilepsy

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 NAOS project word cloud

Explore the words cloud of the NAOS project. It provides you a very rough idea of what is the project "NAOS" about.

manufacturing    synergia    million    magnetic    resistant    leaders    advantages    feasibility    estimates    disease    safety    chain    brings    brain    medication    smaller    small    disorders    realizing    isolation    neurostimulation    completing    fto    nervous    approximately    stimulating    efficiency    finalizing    implanted    medical    implant    people       nerves    treatment    power    compatible    refining    compactness    tissue    planning    neurostimulator    innovative    estimate    business    disruptive    validate    fibres    epilepsy    competitive    innovation    plan    stimulation    replacing    additional    neurological    subcontractors    approved    filing    mri    resonance    specifications    optical    imaging    therapy    wires    medicine    patented    market    billion    suffering    diagnosis    consumption    complete    tunable    fastest    place    improves    prototypes    ultra    size    consists    2021    neurostimulators    patents    electrical    implantable    frequent    opinion    budget    provides    human    renders   

Project "NAOS" data sheet

The following table provides information about the project.

Coordinator
SYNERGIA MEDICAL 

Organization address
address: RUE EMILE FRANCQUI 6
city: MONT-SAINT-GUIBERT
postcode: 1435
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Belgium [BE]
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-07-01   to  2019-11-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    SYNERGIA MEDICAL BE (MONT-SAINT-GUIBERT) coordinator 50˙000.00

Map

 Project objective

The objective of this innovation project is to develop a disruptive implantable neurostimulator for the treatment of epilepsy with the goal to place it on the market by 2021.

Neurostimulation is a $4.7 billion market and one of the fastest-growing areas of medicine, that has been approved for the treatment of several neurological disorders. Among these, epilepsy is the most frequent nervous system disease. Of the 50 million people suffering from epilepsy, with 3.7 million in Europe, approximately one third of them are resistant to medication but respond well to the neurostimulation.

Neurostimulators are small implanted devices stimulating nerves or brain tissue. The innovative aspects of the project are based on a Synergia Medical’s patented concept and consists in replacing wires by optical fibres.

The innovation will improve the traditional therapy and brings the main following competitive advantages: - it renders the neurostimulator compatible with magnetic resonance imaging (MRI) diagnosis - it provides a highly tunable stimulation and ultra low power consumption - it improves safety due to electrical isolation and allow for a smaller size implant

The main objective of this feasibility study is to complete the business plan by: - completing a market study and refining specifications of the neurostimulator with key opinion leaders in the field of epilepsy; - manufacturing prototypes of neurostimulators to validate stimulation capabilities, low power consumption, compactness, optical chain efficiency and estimate production costs; - refining the development and production planning, including budget and human resources, based on cost estimates and test results; - finalizing the selection of subcontractors involved in the production chain; - filing additional patents and realizing a complete FTO.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "NAOS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "NAOS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Dyme (2019)

Dyme gives its users complete control over their financial situation. The Dyme application provides insight into users’ spending and subscriptions, and lets users cancel, negotiate, or switch any cont

Read More  

DeltaQon (2019)

IOT and cloud computing for online medical analysis service platform

Read More  

QTB4AMR (2019)

Utilizing an innovative chemical platform to defeat antimicrobial resistance

Read More